SEVOFLURANE市場的應用、分銷管道和地區

Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球SEVOFLURANE市場規模為 4.011 億美元，到 2032 年將達到 5.495 億美元，2025 年至 2032 年的複合年成長率為 4.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.011億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	4.60%	2032年價值預測	5.495億美元

數字。 2025年SEVOFLURANE各地區市場佔有率（%）

SEVOFLURANE是一種氣味甜美、不易燃、高度氟化的甲基異丙基醚，用作誘導和維持全身麻醉的吸入麻醉劑。它是繼DESFLURANE之後作用速度第二快的揮發性麻醉劑。

市場動態

市場上的公司正專注於引進有助於透過吸入器輸送麻醉的新技術，這可能會在預測期內促進全球SEVOFLURANE市場的成長。例如，2022年4月，全球醫療技術領導者GE醫療集團宣布，其Aisys CS2麻醉輸送系統上用於全身麻醉輸送的Endotide（Et）控制軟體已獲得美國食品藥物管理局（FDA）的上市前核准（PMA）。在美國，GE醫療集團是唯一核准可提供終點濃度控制全身麻醉的製造商。

預計需要麻醉的整容手術的增加將推動全球SEVOFLURANE市場的成長。例如，2022年4月，世界領先的臉部和身體整形及醫療保健協會——美國美容整形學會（Aesthetic Society）發布了其年度《美容整形外科統計數據》，報告顯示，得益於使用該學會新的、更精確的數字技術獲取的數據，美國2021年的整形外科手術數量有所增加。數據顯示，臉部、胸部和身體的整形手術數量大幅增加。自 2020 年以來，腹部整形術、臀部增大術和抽脂術在美國的受歡迎程度都激增了 63%。隆乳、隆乳/乳房提升和乳房提升/縮小手術的數量均增加了 48%。

預計在預測期內，吸入麻醉劑重複使用技術的持續推出將推動成長。例如，2020 年 7 月，無菌藥品生產和供應領域的全球領導者百特國際 (Baxter International) 宣布與醫療技術公司 Zeosys Medical 達成最終協議，將捕獲和再利用麻醉氣體的技術商業化。根據協議，百特將獲得該技術在歐洲以外地區的獨家全球銷售和商業化權利，以及收購 ZeoSys Medical 的獨家選擇權。

本研究的主要特點

本研究報告對全球SEVOFLURANE市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模。
它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採用的競爭策略的重要見解。
全球SEVOFLURANE市場的主要企業根據公司概況、業績、產品系列、地理位置、分銷策略、關鍵發展和策略以及未來計劃等參數進行分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術改進、市場擴張和行銷策略做出明智的決策。
全球SEVOFLURANE市場報告迎合了該行業的各個相關人員，例如投資者、供應商、製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球SEVOFLURANE市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 401.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.60%	2032 Value Projection:	USD 549.5 Mn

Market players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period. For instance, in April 2022, GE Healthcare, a leading global medical technology company, announced that its end-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System has received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA). In the U.S., GE Healthcare is the only manufacturer approved to provide general anesthesia with end-tidal concentration control.

Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market. For instance, in April 2022, The Aesthetic Society, world's leading association dedicated solely to facial and body aesthetic plastic surgery and cosmetic medicine issued its annual Aesthetic Plastic Surgery Statistics, which revealed that aesthetic plastic surgery increased in 2021 in U.S. owing to data acquired using the Society's new, more accurate digital technology. The data shows a large growth in procedures for the face, breasts, and body. Abdominoplasty, buttock augmentation, and liposuction have all seen a 63% surge in popularity since 2020 in U.S. Breast augmentation, augmentation/breast lift, and breast lift/reduction treatments all increased by 48%.

Increasing launches of technology to recycle inhaled anesthetics is expected to fuel the growth over forecast period. For instance, in July 2020, Baxter International Inc., a global leader in the production and delivery of sterile medications, announced a formal agreement with ZeoSys Medical, a medical technology company, to commercialize technology to capture and recycle anesthetic gases. Baxter will have worldwide distribution rights and an exclusive license to commercialize the technology outside of Europe, as well as an exclusive option to acquire ZeoSys Medical, under the terms of the agreement.

Key features of the study:

This report provides an in-depth analysis of global sevoflurane market, provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global sevoflurane market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Baxter, Piramal Pharma Solutions, Manus Aktteva Biopharma LLP, Maruishi Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group, Abbvie, Wellona Pharma, Rewine Pharmaceutical, and Troikaa Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global sevoflurane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sevoflurane market.

Detailed Segmentation:

Global Sevoflurane Market, By Application:
- Induction
- Maintenance
Global Sevoflurane Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sevoflurane Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Sevoflurane Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Impact of COVID-19 on demand and supply of sevoflurane
Impact of COVID-19 on the overall healthcare sector

5. Global Sevoflurane Market, By Application, 2020-2031 (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (US$ Million)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (US$ Million)

6. Global Sevoflurane Market, By Distribution Channel, 2020-2031 (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (US$ Million)

7. Global Sevoflurane Market, By Region, 2020-2031 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2020-2031 (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2020-2031 (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2020-2031 (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2020-2031 (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Application, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2031 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2020-2031 (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Abbott Laboratories*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited